SSX2 and melanoma: Following on this work, Ayyoub et al. utilized fluorescent HLA-A2/SSX2p41–49 multimers to determine the relative frequencies of SSX2 p41–49 CD8+ T cells in melanoma patients with SSX2-positive or negative tumors and in healthy donors [105].